"Got Vaccines ? -- New Business Opportunities & Product Development Challenges" -- a panel discussion, 24 August 2011 (Weds), 6-8 PM, San Diego

---

If you have sincere interest, please join us for the 2nd *FREE*, in situ plasmid-swapping meeting in San Diego of the new LinkedIn.com group:


-->>  Infectious Disease R&D and Business Network

-->>  http://www.linkedin.com/e/-ubgx8c-godydbie-43/vgh/3937807/


And we encourage group members not near San Diego to organize and hold their own similar quorum-sensing plenary all-hands meetings in other cities around the world.


PANEL ABSTRACT:

After decades of getting no respect from BIG Pharma, vaccines got their mojo again ! -- with several attaining, or close to, blockbuster status (US$ 500 million - $ 1 billion in annual sales) including Wyeth's (now Pfizer's) Prevnar, Merck's Gardasil, and GlaxoSmithKline's Cervarix.

Moreover, vaccines are just not for breakfast bugs anymore ! -- rather, vaccine strategies are also being applied to non-I.D. indications such as stroke, Alzheimer's, diabetes, cancers, hypertension, multiple sclerosis, smoking cessation, obesity and Parkinson's.

A new Piribo.com market research report states that the overall global vaccines market was valued at $28 billion in 2010, and is expected to grow at a compound annual rate of 11.5% -- reaching about $57 billion by 2017.

The top vaccine companies include GlaxoSmithKline, Pfizer, Novartis, Merck & Co., SP-MSD and Sanofi.

So if you love the smell of infectious diseases in the morning -- join us for this **FREE** meeting kindly sponsored by the law firm of Sheppard Mullin.


WHEN:  24 August 2011 (Weds), 6-8 PM


Confirmed PANELISTS:

David WHITACRE, Ph.D.
Vice President
Scientific Operations
VLP BIOTECH, INC.
[ VLP = virus-like particle ]
San Diego, CA 92121


PLUS ! -- other PANELISTS INVITED FROM:

Synthetic Genomics Vaccines
Cato Research
Pfizer
Inovio -- and more !


MODERATOR:

David Palella
BIOSCIENCE VENTURES Inc.
San Diego, California
http://www.linkedin.com/in/davidpalella
blog:  http://biobizdev.blogspot.com


WHERE -- & Your host for the evening:

Ms. Amy ROMAKER
Client Service Team
SHEPPARD MULLIN
12275 El Camino Real
Suite 200
San Diego CA 92130-2006

direct tel: 858-720-7403
main tel: 858-720-8900
email:  aromaker@sheppardmullin.com
http://www.sheppardmullin.com


REMINDER:  This is a *FREE* meeting, courtesy of Sheppard Mullin.


NOTA BENE:  NO formal registration is needed; we don't complicate your lives!


For more info & to RSVP, contact:

David A. Palella
BIOSCIENCE VENTURES Inc.
“Global Business Development & Licensing since 1991”
San Diego, Calif.
cell: 619-787-5767
email:  dpalella@gmail.com

---------

POSTED 11 August 2011 by:

David A. Palella
BIOSCIENCE VENTURES Inc.
San Diego, California
cell: 619-787-5767
email:  dpalella@gmail.com
http://www.linkedin.com/in/davidpalella

web site:  http://www.BSVpartners.com

blog:  http://biobizdev.blogspot.com


& Group Founder:

Infectious Disease R&D and Business Network
http://www.linkedin.com/e/-ubgx8c-godydbie-43/vgh/3937807/

Japan Biotech/Biopharma Partnering Forum
http://www.linkedin.com/e/vgh/2857975/

Asia Business & Finance Roundup
http://www.linkedin.com/e/vgh/3132759/

& Co-founder:

Stem Cells & Regenerative Medicine
http://www.linkedin.com/e/vgh/3921448

-----